Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Robert H. Collins, John Nemunaitis, Ofer Shpilberg et al.|Journal of Clinical Oncology|1997Cited by 1.3k
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeJason Coppell, Dietger Niederwieser, Paul G. Richardson et al.|Biology of Blood and Marrow Transplantation|2009Cited by 595
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
Contribution of bone marrow–derived endothelial cells to human tumor vasculatureBrock A. Peters, Christoph Lengauer, Luis A. Díaz et al.|Nature Medicine|2005Cited by 480
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J. Gibson, Benjamin L. Ebert, R. Coleman Lindsley et al.|Journal of Clinical Oncology|2017Cited by 468